Nilotinib Patent Expiration
Nilotinib was first introduced by Flex Pharma Llc
Nilotinib Patents
Given below is the list of patents protecting Nilotinib, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Cavhanza | US11559485 | Orally Disintegrating Tablet Comprising Amorphous Solid Dispersion Of Nilotinib | Apr 30, 2041 | Flex Pharma |
| Cavhanza | US11389450 | Amorphous Nilotinib Microparticles And Uses Thereof | Jan 29, 2041 | Flex Pharma |
| Cavhanza | US12016861 | Amorphous Nilotinib Microparticles And Uses Thereof | Jan 29, 2041 | Flex Pharma |
| Cavhanza | US12029740 | Amorphous Nilotinib Microparticles And Uses Thereof | Jan 29, 2041 | Flex Pharma |
Nilotinib's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List